14-day Premium Trial Subscription Try For FreeTry Free
$311.29
+32.90 (+11.82%)
At Close: May 03, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 AMGN stock ended at $311.29. This is 11.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $308.72 to a day high of $322.60.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Amgen Inc. prices

Date Open High Low Close Volume
Mar 30, 2023 $242.53 $242.81 $240.11 $241.50 2 576 875
Mar 29, 2023 $239.71 $241.59 $238.33 $241.03 2 741 853
Mar 28, 2023 $237.00 $238.68 $236.91 $238.48 1 887 756
Mar 27, 2023 $239.61 $239.95 $235.07 $236.76 2 128 793
Mar 24, 2023 $234.22 $238.50 $233.01 $238.03 2 545 670
Mar 23, 2023 $230.04 $234.10 $229.89 $233.10 2 175 380
Mar 22, 2023 $233.45 $233.95 $229.59 $229.83 1 724 804
Mar 21, 2023 $234.72 $235.28 $231.04 $232.95 2 128 631
Mar 20, 2023 $230.58 $235.16 $230.14 $234.72 2 020 779
Mar 17, 2023 $233.57 $233.81 $228.52 $229.79 7 817 232
Mar 16, 2023 $233.74 $234.66 $230.06 $234.57 2 326 034
Mar 15, 2023 $230.40 $235.57 $228.55 $234.90 2 964 917
Mar 14, 2023 $233.46 $233.46 $229.41 $230.58 3 227 095
Mar 13, 2023 $231.18 $237.27 $230.50 $233.18 3 145 465
Mar 10, 2023 $226.77 $230.28 $225.63 $227.87 2 647 235
Mar 09, 2023 $229.49 $229.83 $225.40 $225.79 1 728 597
Mar 08, 2023 $230.16 $231.80 $227.37 $228.43 1 830 147
Mar 07, 2023 $235.11 $235.20 $228.35 $228.72 2 344 088
Mar 06, 2023 $235.00 $235.63 $233.64 $235.11 2 506 740
Mar 03, 2023 $235.00 $235.89 $233.60 $234.81 1 979 024
Mar 02, 2023 $236.12 $236.37 $233.90 $234.74 1 745 800
Mar 01, 2023 $230.37 $236.44 $230.14 $236.19 2 419 812
Feb 28, 2023 $233.63 $234.47 $231.60 $231.66 2 597 853
Feb 27, 2023 $235.22 $235.22 $232.89 $234.45 1 685 964
Feb 24, 2023 $236.83 $237.06 $233.12 $233.66 1 853 499
Click to get the best stock tips daily for free!

About Amgen Inc.

Amgen. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopaus... AMGN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT